93 related articles for article (PubMed ID: 9819032)
21. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
22. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
23. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
25. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
Warren DL; Morrissey JH; Neuenschwander PF
Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
[TBL] [Abstract][Full Text] [Related]
26. The cofactor function of the N-terminal domain of tissue factor.
Kittur FS; Manithody C; Morrissey JH; Rezaie AR
J Biol Chem; 2004 Sep; 279(38):39745-9. PubMed ID: 15252050
[TBL] [Abstract][Full Text] [Related]
27. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
Prasad R; Sen P
Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
[TBL] [Abstract][Full Text] [Related]
28. Extensive small-angle X-ray scattering studies of blood coagulation factor VIIa reveal interdomain flexibility.
Mosbaek CR; Nolan D; Persson E; Svergun DI; Bukrinsky JT; Vestergaard B
Biochemistry; 2010 Nov; 49(45):9739-45. PubMed ID: 20873866
[TBL] [Abstract][Full Text] [Related]
29. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
30. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
31. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
32. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
Beeler DL; Aird WC; Grant MA
J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
[TBL] [Abstract][Full Text] [Related]
33. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
[TBL] [Abstract][Full Text] [Related]
34. Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis.
Payne MA; Neuenschwander PF; Johnson AE; Morrissey JH
Biochemistry; 1996 Jun; 35(22):7100-6. PubMed ID: 8679536
[TBL] [Abstract][Full Text] [Related]
35. Gene expression analysis of HUVEC in response to TF-binding.
Grosser M; Magdolen V; Baretton G; Luther T; Albrecht S
Thromb Res; 2011 Mar; 127(3):259-63. PubMed ID: 21186047
[TBL] [Abstract][Full Text] [Related]
36. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
37. The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Narasimhan LS; Zhang E; Rapundalo ST; Saiya-Cork K; Leadley RJ; Edmunds JJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):1060-4. PubMed ID: 16289811
[TBL] [Abstract][Full Text] [Related]
38. Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.
Madsen JJ; Persson E; Olsen OH
J Thromb Haemost; 2015 Feb; 13(2):262-7. PubMed ID: 25403348
[TBL] [Abstract][Full Text] [Related]
39. A loop of coagulation factor VIIa influencing macromolecular substrate specificity.
Bjelke JR; Persson E; Rasmussen HB; Kragelund BB; Olsen OH
FEBS Lett; 2007 Jan; 581(1):71-6. PubMed ID: 17182039
[TBL] [Abstract][Full Text] [Related]
40. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]